Evolution of the sabin type 1 poliovirus in humans: Characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7758-7768

  Georgescu, Maria Magdalena ^a,d   Balanant, Jean ^a   Macadam, Andrew ^b   Otelea, Dan ^c   Combiescu, Mariana ^c   Combiescu, Andrei Aubert ^c   Crainic, Radu ^a   Delpeyroux, Francis ^a  

^a INSTITUT PASTEUR   (France)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c CANTACUZINO INSTITUTE   (Romania)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; CLINICAL ARTICLE; EVOLUTION; GENE SEQUENCE; HUMAN; HUMAN CELL; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; GENOTYPE; HUMANS; MICE; PHENOTYPE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RNA, VIRAL; SEROTYPING; TUMOR CELLS, CULTURED; VIRULENCE; VIRUS REPLICATION;

EID: 0030796304     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7758-7768.1997     Document Type: Article

References (68)

1. Abe, S., Y. Ota, Y. Doi, A. Nomoto, T. Nomura, K. M. Chumakov, and S. Hashizume. 1995. Studies on neurovirulence in poliovirus-sensitive transgenie mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology 210:160-166.
2. Almond, J. W., A. J. Cann, P. D. Minor, P. Reeve, G. C. Schild, R. Hauptmann, and G. Stanway. 1984. Nucleotide sequence from neurovirulent and attenuated strains of type 3 poliovirus. Rev. Infect. Dis. 6(Suppl.):487-493.
3. Balanant, J., S. Guillot, A. Candrea, F. Delpeyroux, and R. Crainic. 1991. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184:645-654.
4. Barlean, L., G. Avram, E. Pavlov, and F. Cotor. 1994. Investigation of five cases of vesicular enteroviral stomatitis with exanthema induced by coxsackie A5 virus. Rev. Roum. Virol. 45:3-9.
5. Borzakian, S., I. Pelletier, V. Calvez, and F. Colbere-Garapin. 1993. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:2914-2917.
6. Bouchard, M., D. H. Lam, and V. Racaniello. 1995. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine J. Virol. 69:4972-4978.
7. Christodoulou, C., F. Colbère-Garapin, A. Macadam, L. F. Taffs, S. Marsden, P. D. Minor, and F. Horaud. 1990. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64:4922-4929.
8. Chumakov, K. M., E. M. Dragunsky, L. P. Norwood, M. P. Douthitt, Y. X. Ran, R. E. Taffs, J. Ridge, and I. S. Levenbook. 1994. Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. J. Med. Virol. 42:79-85.
9. Colbère-Garapin, F., C. Christodoulou, R. Crainic, A. C. Garapin, and A. Candrea. 1988. Addition of a foreign oligopeptide to the major capsid protein of poliovirus. Proc. Natl. Acad. Sci. USA 85:8668-8672.
10. Colston, E., and V. R. Racaniello. 1994. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J. 13:5855-5862.
11. Contreras, G., K. Dimock, J. Furesz, C. Gardell, D. Hazlett, K. Kurpinski, G. McCorkle, and L. Wu. 1992. Genetic characterization of Sabin type-1 and type-3 poliovaccine virus following serial passage in the human intestinal tract. Biologicals 20:15-26.
12. Couderc, T., F. Delpeyroux, H. Le Blay, and B. Blondel. 1996. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J. Virol. 70:305-312.
13. Crainic, R., P. Couillin, B. Blondel, N. Cabau, A. Boué, and F. Horodniceanu. 1983. Natural variation of poliovirus neutralization epitope. Infect. Immun. 41:1217-1225.
14. de la Torre, J. C., C. Giachetti, B. L. Semler, and J. J. Holland. 1992. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc. Natl. Acad. Sci. USA 89:2531-2535.
15. Dildine, S. L., and B. L. Semler. 1989. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5′ noncoding region of genomic RNA. J. Virol. 63:847-862.
16. Dildine, S. L., and B. L. Semler. 1992. Conservation of RNA-protein interactions among picornaviruses. J. Virol. 66:4364-4376.
17. Dunn, G., N. T. Begg, N. Cam Mack, and P. D. Minor. 1990. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J. Med. Virol. 32:92-95.
18. Fichot, O., and M. Girard. 1990. An improved method for sequencing of RNA templates. Nucleic Acids Res. 18:6162.
19. Filman, D. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-1579.
20. Friedrich, F., A. M. Filippis, F. C. Ferreira, M. J. C. Oliveira, H. G. Schatzmayr, and E. E. Da-Silva. 1996. Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil. Braz. J. Med. Biol. Res. 29:15-18.
21. Friedrich, F., A. M. B. Filippis, F. C. Ferreira, H. G. Schatzmayr, and E. E. Dasilva. 1995. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil. Acta Virol. 39:23-29.
22. Furione, M., S. Guillot, D. Otelea, J. Balanant, A. Candrea, and R. Crainic. 1993. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196:199-208.
23. Georgescu, M. M., M. Tardy-Panit, S. Guillot, R. Crainic, and F. Delpey-roux. 1995. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J. Virol. 69:5278-5286.
24. Georgescu, M. M., F. Delpeyroux, M. Tardy-Panit, J. Balanant, M. Combiescu, A. Aubert Combiescu, S. Guillot, and R. Crainic. 1994. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68:8089-8101.
25. Guillot, S., D. Otelea, F. Delpeyroux, and R. Crainic. 1994. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 12:503-507.
26. Harber, J., G. Bernhardt, H. H. Lu, J. Y. Sgro, and E. Wimmer. 1995. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology 214:559-570.
27. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
28. Horie, H., S. Koike, T. Kurata, Y. Satoyoshida, I. Ise, Y. Ota, S. Abe, K. Hioki, H. Kato, C. Taya, T. Nomura, S. Hashizume, H. Yonekawa, and A. Nomoto. 1994. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J. Virol. 68:681-688.
29. Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63:1302-1309.
30. Kean, K. M., C. Wychowski, H. Kopecka, and M. Girard. 1986. Highly infectious plasmids carrying poliovirus cDNA are capable of replication in transfected simian cells. J. Virol. 59:490-493.
31. Kew, O. M., and B. K. Nottay. 1984. Evolution of the oral poliovaccine strains in humans occur by both mutation and intramolecular recombination, P- 357-367. In R. Chanock and R. Lerner (ed.), Modern approaches to vaccines. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
32. Kirkegaard, K. 1990. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J. Virol. 64:195-206.
33. Kohara, M., S. Abe, S. Kuge, B. L. Semler, T. Komatsu, M. Arita, H. Itoh, and A. Nomoto. 1986. An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology 151:21-30.
34. Li, J., L. B. Zhang, T. Yoneyama, H. Yoshida, H. Shimizu, K. Yoshii, M. Hara, T. Nomura, H. Yoshikura, T. Miyamura, and A. Hagiwara. 1996. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Arch. Virol. 141:1047-1054.
35. pro. J. Virol. 68:7507-7515.
36. Lu, Z. B., G. V. Rezapkin, M. P. Douthitt, Y. X. Ran, D. M. Asher, I. S. Levenbook, and K. M. Chumakov. 1996. Limited genetic changes in the Sabin 1 strain of poliovirus occurring in the central nervous system of monkeys. J. Gen. Virol. 77:273-280.
37. Macadam, A. J., C. Arnold, J. Howlett, A. John, S. Marsden, F. Taffs, P. Reeve, N. Hamada, K. Wareham, J. Almond, N. Cam mack, and P. D. Minor. 1989. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172:408-414.
38. Macadam, A. J., G. Ferguson, J. Burlison, D. Stone, R. Skuce, J. W. Almond, and P. D. Minor. 1992. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 189:415-422.
39. Macadam, A. J., S. R. Pollard, G. Ferguson, G. Dunn, R. Skuce, J. W. Almond, and P. D. Minor. 1991. The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181:451-458.
40. Martin, A., D. Bénichou, T. Couderc, J. Hogle, C. Wychowsky, S. van der Werf, and M. Girard. 1991. Use of type 1/2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology 180:648-658.
41. McGoldrick, A., A. J. Macadam, G. Dunn, A. Rowe, J. Burlison, P. D. Minor, J. Meredith, D. J. Evans, and J. W. Almond. 1995. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J. Virol. 69:7601-7605.
42. Melnick, J. L. 1996. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 655-712. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Raven Publishers, Philadelphia, Pa.
43. Minor, P. D. 1992. The molecular biology of poliovaccines. J. Gen. Virol. 73:3065-3077.
44. Murdin, A. D., and E. Wimmer. 1989. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. J. Virol. 63:5251-5257.
45. Muzvehenko, A. R., G. Y. Lipskaya, S. V. Maslova, Y. V. Svitkin, E. V. Pilipenko, B. K. Nottay, O. Kew, and V. I. Agol. 1991. Coupled mutations in the 5′-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res. 21:111-122.
46. Najita, L., and P. Sarnow. 1990. Oxidation-reduction sensitive interaction of a cellular 50-kDa protein with an RNA hairpin in the 5′ noncoding region of the poliovirus genome. Proc. Natl. Acad. Sci. USA 87:5846-5850.
47. Nakano, J. H., M. H. Hatch, M. L. Thieme, and B. Nottay. 1978. Parameters for differentiating vaccine-derived and wild poliovirus strains. Prog. Med. Virol. 24:178-206.
48. Nicholson, R., J. Pelletier, S. Y. Le, and N. Sonenberg. 1991. Structural and functional analysis of the ribosome landing pad of poliovirus type-2. In vivo translation studies. J. Virol. 65:5886-5894.
49. Nomoto, A., T. Omata, H. Toyoda, S. Kuge, H. Horie, Y. Kataoka, Y. Genba, Y. Nakano, and N. Imura. 1982. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc. Natl. Acad. Sci. USA 79:5793-5797.
50. Nottay, B. K., O. M. Kew, M. H. Hatch, J. T. Heyward, and J. F. Obijeski. 1981. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 108:405-423.
51. Omata, T., M. Kohara, S. Kuge, T. Komatsu, S. Abe, B. L. Semler, A. Kameda, H. Itoh, M. Arita, E. Wimmer, and A. Nomoto. 1986. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58:348-358.
52. Otelea, D., S. Guillot, M. Furione, A. A. Combiescu, J. Balanant, A. Candrea, and R. Crainic. 1993. Genomic modifications in naturally occuring neurovirulent revenants of Sabin 1 polioviruses. Dev. Biol. Stand. 78:33-38.
53. Pelletier, J., G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Capindependent translation of poliovirus mRNA is conferred by sequence elements within the 5′ noncoding region. Mol. Cell. Biol. 8:1103-1112.
54. Percy, N., G. J. Belsham, J. K. Brangwyn, M. Sullivan, D. M. Stone, and J. W. Almond. 1992. Intracellular modifications induced by poliovirus reduce the requirement for structural motifs in the 5′ noncoding region of the genome involved in internal initiation of protein synthesis. J. Virol. 66:1695-1701.
55. Pilipenko, E. V., V. M. Blinov, L. I. Roma Nova, A. N. Sinyakov, S. V. Maslova, and V. I. Agol. 1989. Conserved structural domains in the 5′-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168:201-209.
56. Reed, L. J., and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
57. Rezapkin, G. V., K. M. Chumakov, Z. Lu, Y. Ran, E. M. Dragunsky, and I. S. Levenbook. 1994. Microevolulion of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202:370-378.
58. Rico-Hesse, R., M. A. Pallansch, B. K. Nottay, and O. M. Kew. 1987. Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311-322.
59. Sabin, A. 1985. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J. Infect. Dis. 151:420-436.
60. Sabin, A. B., and L. R. Boulger. 1973. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1:115-118.
61. Skinner, M. A., V. R. Racaniello, G. Dunn, J. Cooper, P. D. Minor, and J. W. Almond. 1989. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 207:379-392.
62. Strebet, P. M., A. Aubert-Combiescu, N. Ion-Nedelcu, S. Biberi-Moroeanu, M. Combiescu, R. W. Sutter, O. M. Kew, M. A. Pallansch, P. A. Patriarca, and S. L. Cochi. 1994. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am. J. Epidemiol. 140:1111-1124.
63. Strebel, P. M., R. W. Sutler, S. L. Cochi, R. J. Biellik, E. W. Brink, O. M. Kew, M. A. Pallansch, W. A. Orenstein, and A. R. Hinman. 1992. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin. Infect. Dis. 14:568-579.
64. Sutter, R. W., E. W. Brink, S. L. Cochi, O. M. Kew, W. A. Orenstein, R. J. Biellik, and A. R. Hinman. 1989. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am. J. Public Health 79: 495-498.
65. Sutter, R. W., S. L. Cochi, and P. A. Patriarca. 1993. Epidemiologic and laboratory classification systems for paralytic poliomyelitis cases, p. 235-247. In E. Kurstak (ed.), Measles and poliomyelitis. Vaccine, Immunization and Control. Springer-Verlag, Vienna, Austria.
66. Tardy-Panit, M., B. Blondel, A. Martin, F. Tekaia, F. Horaud, and F. Delpeyroux. 1993. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J. Virol. 67:4630-4638.
67. Wimmer, E., C. U. T. Hellen, and X. M. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353-436.
68. Zavate, O., G. Avram, E. Pavlov, A. Burlea-Iriciuc, A. Ivan, and F. Cotor. 1984. Coxsackie A virus-associated herpetiform angina. Virologie 35:49-53.